#EULAR2020

Sanofi’s Sarclisa approved in Europe for relapsed and refractory multiple myeloma

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

European Commission approved Zolgensma, activates “Day one” access program

HAS gave favorable opinion for reimbursing Darzalex for treating multiple myeloma naïve patients

EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation

PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE

Novo Nordisk’s Rybelsus approved by European Union

EMA approved Mayzent (siponimod) for secondary progressive multiple sclerosis

CHMP gave positive opinions for Beovu and Recarbrio